Soluble urokinase plasminogen activator receptor
8 papers study it20 more mention it2 findings
1 new paper in 30 daysSee all 28
- Human trial2
- Humans6
Interventions
1Fasting-mimicking diet
downin humans1
1 study
Fasting-mimicking diet
downin humans1
Fasting-mimicking diet decreases soluble urokinase plasminogen activator receptor in humans (−156.6 (−172.9, −140.4) pg/mL, P ≤ 0.05).
“suPAR decreased after 3 [−214.8 (−238.4, −191.3) pg/mL; P ≤ 0.05] and after 6 diet cycles [−156.6 (−172.9, −140.4) pg/mL; P ≤ 0.05].”
Human trial6 diet cyclesn = 41
The Journal of clinical endocrinology and metabolism
Fasting-mimicking diet decreases soluble urokinase plasminogen activator receptor in humans (-156.6 (-172.9, -140.4) pg/mL).
“soluble urokinase plasminogen activator receptor [-156.6 (-172.9, -140.4) pg/mL; P ≤ 0.05]”
Human trial6 monthsn = 40
The Journal of clinical endocrinology and metabolism
Latest
4 papers in 12 monthsBiological Psychology
Social network composition and inflammation at midlife: A socioemotional selectivity theory perspective
Cohort study of 404 peoplePopulations
Cardiac Failure Review
Prevalence and Prognostic Significance of Malnutrition Assessed by Two Scoring Systems in Hospitalised Elderly Patients with Chronic Heart Failure
Cohort study of 597 peopleChronic heart failure
Brain, Behavior, and Immunity
Executive function and soluble urokinase-type plasminogen activator receptor (suPAR): a longitudinal study of midlife adults
Cohort study of 599 peopleBiomarkers
medRxiv
A signature of pre-operative biomarkers of cellular senescence to predict risk of cardiac and kidney adverse events after cardiac surgery
Preprint: cohort study of 331 peopleBiomarkers
The Journal of Clinical Endocrinology and Metabolism
Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study
Randomized trial in 40 peopleDiabetic nephropathy
BMC Geriatrics
Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
Cohort study of 120 peopleBiomarkers
ESC Congress 2026 Abstract
Fourteen-year risk of MACE stratified by NT-proBNP and inflammatory biomarkers in type 2 diabetes
Study in peopleBiomarkers
Basic & Clinical Pharmacology & Toxicology
Low-Dose Fisetin Supplementation and Its Association With Chronic Inflammation in Middle-Aged and Older Adults: Study Protocol for a Triple-Blind, Randomised, Placebo-Controlled Trial
Study protocolFisetin